Recommendations for antibiotic selection for severe nosocomial infections.

Simple item page
dc.contributor.authorMensa, J
dc.contributor.authorBarberán, J
dc.contributor.authorFerrer, R
dc.contributor.authorBorges, M
dc.contributor.authorRascado, P
dc.contributor.authorMaseda, E
dc.contributor.authorOliver, A
dc.contributor.authorMarco, F
dc.contributor.authorAdalia, R
dc.contributor.authorAguilar, G
dc.contributor.authorEstella, A
dc.contributor.authorLeón López, R
dc.contributor.authorRobles Marcos, M S
dc.contributor.authorGonzález de Molina, F J
dc.contributor.authorSerrano García, R
dc.contributor.authorSalavert, M
dc.contributor.authorFernández Gómez, J
dc.contributor.authorPoliakova, Y
dc.contributor.authorPasquau, J
dc.contributor.authorAzanza, J R
dc.contributor.authorBou Arévalo, G
dc.contributor.authorLLinares Mondéjar, P
dc.contributor.authorCardinal-Fernández, P
dc.contributor.authorSoriano, A
dc.date.accessioned2025-01-07T12:58:30Z
dc.date.available2025-01-07T12:58:30Z
dc.date.issued2021-10-25
dc.description.abstractSevere infection and its evolution to sepsis are becoming more prevalent every day and are among the leading causes of critical illness and mortality. Proper management is crucial to improve prognosis. This document addresses three essential points that have a significant impact on this objective: a) early recognition of patients with sepsis criteria, b) identification of those patients who suffer from an infection and have a high risk of progressing to sepsis, and c) adequate selection and optimization of the initial antimicrobial treatment.
dc.identifier.doi10.37201/req/126.2021
dc.identifier.essn1988-9518
dc.identifier.pmcPMC8638841
dc.identifier.pmid34693705
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8638841/pdf
dc.identifier.unpaywallURLhttps://seq.es/wp-content/uploads/2021/10/mensa25oct2021.pdf
dc.identifier.urihttps://hdl.handle.net/10668/25096
dc.issue.number5
dc.journal.titleRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
dc.journal.titleabbreviationRev Esp Quimioter
dc.language.isoen
dc.organizationSAS - Hospital Universitario de Jerez de la Frontera
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.page.number511-524
dc.pubmedtypeJournal Article
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectantimicrobial treatment
dc.subjectceftazidime-avibactam
dc.subjectceftolozane-tazobactam
dc.subjectmeropenem
dc.subjectoptimization
dc.subjectsepsis
dc.subjectseptic shock
dc.subjectsevere infection
dc.subject.meshAnti-Bacterial Agents
dc.subject.meshCeftazidime
dc.subject.meshCephalosporins
dc.subject.meshCross Infection
dc.subject.meshHumans
dc.subject.meshTazobactam
dc.titleRecommendations for antibiotic selection for severe nosocomial infections.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number34

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC8638841.pdf
Size:
1.04 MB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario de Jerez de la Frontera
SAS - Hospital Universitario Reina Sofía
SAS - Hospital Universitario Virgen de las Nieves

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía